141 related articles for article (PubMed ID: 37739836)
1. [Sacral neuromodulation for bladder voiding dysfunction: Experience at a French university center].
Ducrot Q; Brierre T; Roulette P; Soulié M; Castel-Lacanal E; Gamé X
Prog Urol; 2023 Dec; 33(17):1062-1072. PubMed ID: 37739836
[TBL] [Abstract][Full Text] [Related]
2. [Sacral neuromodulation: results of a monocentric study of 93 patients].
Donon L; Robert G; Ballanger P
Prog Urol; 2014 Dec; 24(17):1120-31. PubMed ID: 25310913
[TBL] [Abstract][Full Text] [Related]
3. Urodynamic findings during the filling phase in neurogenic bladder patients with or without vesicoureteral reflux who have undergone sacral neuromodulation.
Chen G; Liao L; Wang Y; Ying X
Neurourol Urodyn; 2020 Jun; 39(5):1410-1416. PubMed ID: 32282088
[TBL] [Abstract][Full Text] [Related]
4. Sacral neuromodulation in the management of non-obstructive urinary retention: Test phase and predictive factors.
Al Hashimi I; Saussine C; Tricard T
Prog Urol; 2023 Mar; 33(4):217-222. PubMed ID: 36402689
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of sacral neuromodulation on urological diseases: a multicentric research project.
Cardarelli S; D'Elia C; Cerruto MA; Curti P; Ostardo E; Signorello D; Pastorello M; Caleffi G; Molon A; Artibani W
Urologia; 2012; 79(2):90-6. PubMed ID: 22610844
[TBL] [Abstract][Full Text] [Related]
6. The value of urodynamic tools to guide patient selection in sacral neuromodulation.
Drossaerts J; Rademakers K; van Koeveringe G; Van Kerrebroeck P
World J Urol; 2015 Nov; 33(11):1889-95. PubMed ID: 25680936
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the efficacy of sacral neuromodulation in the treatment of voiding dysfunction after endometriosis surgery.
Aublé A; Gazdovich S; Dégremont S; Pfister C; Roman H; Bridoux V; Leroi AM; Cornu JN
Prog Urol; 2023 Dec; 33(17):1073-1082. PubMed ID: 37951811
[TBL] [Abstract][Full Text] [Related]
8. Long-term follow-up of sacral neuromodulation for lower urinary tract dysfunction.
Peeters K; Sahai A; De Ridder D; Van Der Aa F
BJU Int; 2014 May; 113(5):789-94. PubMed ID: 24238278
[TBL] [Abstract][Full Text] [Related]
9. Contribution of sacral neuromodulation to manage persistent voiding dysfunction after surgery for deep infiltrating endometriosis with colorectal involvement: preliminary results.
Nyangoh Timoh K; Canlorbe G; Verollet D; Peyrat L; Ballester M; Amarenco G; Darai E
Eur J Obstet Gynecol Reprod Biol; 2015 Jul; 190():31-5. PubMed ID: 25966436
[TBL] [Abstract][Full Text] [Related]
10. Results of Sacral Neuromodulation Therapy for Urinary Voiding Dysfunction: Five-Year Experience of a Retrospective, Multicenter Study in China.
Zhang P; Wang JY; Zhang Y; Liao L; Lv JW; Ling Q; Wei ZQ; Zhong T; Xu ZH; Wen W; Li JY; Luo DY
Neuromodulation; 2019 Aug; 22(6):730-737. PubMed ID: 30609180
[TBL] [Abstract][Full Text] [Related]
11. [Sacral neuromodulation in urology. The emperor's new clothes or effective high-tech medicine?].
Hoda MR; Fornara P
Urologe A; 2010 Oct; 49(10):1254-9. PubMed ID: 20859609
[TBL] [Abstract][Full Text] [Related]
12. The Value of Ambulatory Urodynamics in the Evaluation of Treatment Effect of Sacral Neuromodulation.
Drossaerts J; Rademakers KLJ; Rahnama'i SM; Marcelissen T; Van Kerrebroeck P; van Koeveringe G
Urol Int; 2019; 102(3):299-305. PubMed ID: 30612126
[TBL] [Abstract][Full Text] [Related]
13. [Posterior sacral root neuromodulation in the treatment of chronic urinary dysfunction].
Linares Quevedo AI; Jiménez Cidre MA; Fernández Fernández E; Perales Cabanas L; Briones Mardones G; Pozo Mengual B; Sáenz Medina J; Escudero Barrilero A
Actas Urol Esp; 2002 Apr; 26(4):250-60. PubMed ID: 12090182
[TBL] [Abstract][Full Text] [Related]
14. Current and future techniques of neuromodulation for bladder dysfunction.
Sherman ND; Amundsen CL
Curr Urol Rep; 2007 Nov; 8(6):448-54. PubMed ID: 18042323
[TBL] [Abstract][Full Text] [Related]
15. The current use of neuromodulation for bladder dysfunction.
Sherman ND; Amundsen CL
Minerva Ginecol; 2006 Aug; 58(4):283-93. PubMed ID: 16957672
[TBL] [Abstract][Full Text] [Related]
16. The long-term efficacy of sacral neuromodulation in the management of intractable cases of bladder pain syndrome: 14 years of experience in one centre.
Gajewski JB; Al-Zahrani AA
BJU Int; 2011 Apr; 107(8):1258-64. PubMed ID: 20883483
[TBL] [Abstract][Full Text] [Related]
17. [Sacral neuromodulation in under- and overactive detrusor-quo vadis? : Principles and developments].
Girtner F; Burger M; Mayr R
Urologe A; 2019 Jun; 58(6):634-639. PubMed ID: 31139864
[TBL] [Abstract][Full Text] [Related]
18. Pediatric sacral nerve stimulator explanation due to complications or cure: a survival analysis.
Rensing AJ; Szymanski KM; Dunn S; King S; Cain MP; Whittam BM
J Pediatr Urol; 2019 Feb; 15(1):39.e1-39.e6. PubMed ID: 30473473
[TBL] [Abstract][Full Text] [Related]
19. Sacral neuromodulation in urological indications: the Finnish experience.
Vaarala MH; Tammela TL; Perttilä I; Luukkonen P; Hellström P
Scand J Urol Nephrol; 2011 Feb; 45(1):46-51. PubMed ID: 20961268
[TBL] [Abstract][Full Text] [Related]
20. Sacral neuromodulation treatment for urinary voiding dysfunctions: results of treatment with the largest single-center series in a tertiary referral center in Turkey.
Kütükoğlu MU; Altuntaş T; Şahin B; Onur AR
Turk J Med Sci; 2023 Feb; 53(1):206-210. PubMed ID: 36945940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
